Involved in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, US and world wide.
Holdco Nuvo Group D.G Ltd is at the forefront of medical device innovation, specializing in the research, development, and global marketing of advanced technologies for pregnancy monitoring. Operating in Israel, the United States, and internationally, the company focuses on enhancing maternal and fetal health through its pioneering INVU platform. This platform empowers expectant mothers with a self-administered wireless sensory band, allowing continuous monitoring of maternal and fetal heart rates as well as uterine activity. The INVU platform supports monitoring from the 32nd week of pregnancy until the onset of labor, both at home and in clinical settings.
The INVU platform integrates a wireless sensory band equipped with multi-modality technology to capture essential physiological signals crucial for maternal and fetal health monitoring. This data is processed and analyzed in a cloud computing environment, enabling real-time insights and personalized health reports. These insights are then transmitted to both the expectant mother and her obstetrician through intuitive digital visualization tools, facilitating informed decision-making and proactive healthcare management.
Established in 2006 and headquartered in Tel Aviv, Israel, Holdco Nuvo Group D.G Ltd has garnered international recognition for its commitment to advancing pregnancy monitoring technologies. The company's strategic collaborations with industry leaders such as Royal Philips and Charite " Universitätsmedizin Berlin underscore its dedication to innovation and healthcare excellence. With a strong foundation in research and development, Holdco Nuvo Group D.G Ltd continues to lead the charge in improving maternal and fetal health outcomes worldwide.